Medical device maker DexCom announced Tuesday that the company has received a de novo clearance from the FDA to sell its latest continuous glucose monitoring system — the G6 — that requires no ...
Dexcom CGM use is proven to improve glycemic control 1,2 and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring. 3 BURNABY, British ...
Life-changing CGM system indicated for persons age 2 years and older, now available for wear on back of the upper arm, giving patients more options EDINBURGH, Scotland, June 9, 2020 /PRNewswire/ -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results